When stratifying WD/DD LPS samples by IGF2BP3 protein expression, IGF2BP3+ was again associated with worse survival (mOS: 3.7 vs. 13.8 years, p < 0.0001) (Figure 4A). The gene discussed is IGF2BP3; the disease is Wilson disease.